TJ0113 capsules for age-related hearing loss
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests an investigational drug, TJ0113, taken by mouth, to see if it can safely improve hearing in people with age-related hearing loss. It focuses on adults aged 65 to 80 with moderate to severe hearing loss in both ears.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 65 and 80 years old.
- You have hearing loss in both ears that is similar in severity and has lasted more than 3 months.
- Your hearing loss is moderate to severe (not mild or profound).
- You either do not use hearing aids, or you have used them regularly for over 3 years but stopped at least 3 months ago.
- You do not have other ear problems like infections, implants, or a history of sudden deafness.
- Your hearing loss is due to aging, not other causes like noise, injury, or certain medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (DX243) to see if it is safe and well-tolerated in people with hearing difficulties, especially trouble hearing speech in noisy environments. The goal is to understand how the body processes this medicine and whether it might help improve hearing.
This trial compares two types of hearing aids (one made in China, one imported) to see which works better for age-related hearing loss. You might benefit if you have moderate to severe hearing loss and are willing to test both devices.
This study looks at how hearing loss in older adults relates to thinking and memory problems like dementia. It aims to improve hearing care and identify early signs of cognitive decline.
This study is developing a system to evaluate and improve hearing for people with congenital hearing loss. It compares participants who have hearing loss (and have used hearing aids, cochlear implants, or gene therapy) with healthy controls, to better understand and treat hearing challenges.
This trial tests whether huperzine A can improve hearing-related symptoms along with tinnitus (ringing) and mild cognitive (memory/thinking) problems. If you have mild-to-moderate hearing loss plus bothersome constant tinnitus and some cognitive decline, this study may help researchers see if the treatment makes a difference.
This study tests an investigational drug called TRTL-913 in healthy volunteers first, then in adults with constant ringing in the ears (tinnitus). The goal is to see if it is safe and if it reduces tinnitus symptoms.
Hear when a new Age-related Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.